Management

Bill Hoffman

Bill Hoffman

Chief Executive Officer
Bill has focused on early stage companies with novel devices in new markets. Prior to Inari Medical, Bill served as CEO of Visualase, Inc., which developed and sold lasers for minimally invasive neurosurgery. The company was acquired by Medtronic for $105M in July, 2014, having raised less than $10m in equity funding. Prior to Visualase, Bill was Vice President of Sales at FoxHollow, Inc., helping to build a commercial team and revenue ramp that led to a successful IPO in 2004 and an acquisition by EV3 in 2007. Bill’s first early stage med tech experience was as head of sales at RITA Medical Systems, an interventional oncology company that enjoyed a successful IPO in 2000. He spent the early part of his career in various sales roles at Ethicon and Medtronic.
Drew Hykes

Drew Hykes

Chief Commercial Officer
Drew is a proven medical device operating executive with broad functional, geographic and sector experience. From 2012-2016 Drew served as the VP of Commercial Operations at Sequent Medical where he led the commercialization strategy for the WEB Aneurysm Embolization system from early prototype to broad adoption in the European market. Sequent was acquired by Terumo Corporation in July 2016 for $380 million. Prior to Sequent, Drew spent 11 years at Medtronic. His roles at Medtronic included the VP of Marketing for the AF Solutions business, VP of Clinical and Regulatory for the AF Solutions business and Director of Investor Relations. Drew also spent three years on an expatriate assignment in Europe leading the launch of Medtronic’s first drug eluting coronary stent. Prior to Medtronic, he spent four years at ABN AMRO bank in Chicago focused on healthcare transactions. He earned a B.B.A. in Finance from the University of Wisconsin and an MBA from Harvard Business School.
Mitch Hill

Mitch Hill

Chief Financial Officer
Mitch has extensive experience leading financial functions at both large and small companies. With senior executive experience at a number of private equity and venture capital-backed companies in medical device and health care services, Mitch has led many organizations to scale their financial strategies during rapid growth, such as Cameron Health which was acquired by BSX and Visiogen which was acquired by ABT. Prior to entering the health care industry, served as CFO of Walt Disney Imagineering and as President and CFO of Buy.com, Inc., including at the time of its initial public offering in February 2000. Mitch brings a wealth of financial knowledge and experience from high growth industries and an understanding of the challenges and landscape of modern healthcare. He earned a BS in Accounting from Brigham Young Univ. and an MBA from Harvard Business School.
Dr. Thomas Tu

Dr. Tom Tu

Chief Medical Officer
Dr. Thomas Tu joins Inari Medical after practicing Interventional Cardiology for 16 years. He is a graduate of Harvard Medical School and completed residency at Massachusetts General Hospital. He was trained in Interventional Cardiology, Peripheral Vascular Intervention, and Structural Heart Disease at Beth Israel Deaconess Medical Center. Most recently, he was the Cath Lab director and leader of the Pulmonary Embolism, complex PCI, and TAVR programs at Baptist Health Louisville. Dr. Tu helped develop the early phase technology that allowed Inari Medical to optimize patient outcomes. He also served as the presenter for the FLARE IDE trial of the Inari FlowTriever Retrieval/Aspiration System. This study led to FDA 510 (k) clearance for treatment of pulmonary embolism, the first thrombectomy device cleared for that indication.
Paul Koehn

Paul Koehn

Vice President of Operations
Paul brings to Inari over 25 years of experience in high volume, high quality growth operations across multiple industries. With experience both in domestic and global strategic planning, Paul’s work in product development and production has resulted in 4 revolutionary device platforms and 150 total products. Paul has a excellent track record in overall business performance exceeding 80% gross margin on all products, 92% gross margin on devices, and established scalable production and distribution capacity to greater than 4 times demand. In addition, Paul also brings a understanding of construction of manufacturing facilities and corporate offices. Paul was most recently the Senior Vice President of Quality and Operations at Cardiovascular Systems Inc. where he was crucial in the growth of the company from $0 revenue in 2007 to over $200M in 2017.
Tara Dunn

Tara Dunn

Vice President of Clinical Affairs and Market Development
Tara has extensive multi-functional medical device experience across a range of start-ups and larger organizations. Her most recent role was as the Venous Business Segment Leader at Volcano Corporation, acquired by Philips in 2015. Tara’s venous business experienced explosive triple digit growth in her time at the helm. Prior to Philips Volcano, she worked at Medtronic in Corporate Development where she participated in numerous transactions including the ~$816M acquisition of Kanghui Holdings in China and the divestiture of its Physio-Control business unit to Bain Capital for $487M. Tara also worked as a project leader at a healthcare strategy consulting firm called Health Advances and as Manager, Clinical and Regulatory Affairs at InfraReDx. She earned an A.B. in Biology from Harvard University, a M.S. in Regulatory Affairs and Health Policy from the Massachusetts College of Pharmacy and a M.B.A from Harvard Business School. Tara was a member of the National Championship winning ice hockey team and Ivy league championship team in softball while at Harvard. She also went on to compete in the National Women’s Hockey League (NWHL) for two seasons.
John Borrell

John Borrell

Vice President of Sales
John brings over 25 years of extensive commercial experience with early stage and mature medical device companies. His most recent roles were VP of Global Sales and Marketing at Trireme Medical and Area VP of Sales at Medtronic/Covidien Venous Vascular. Prior to that he was VP of Sales and Marketing at Cardiovascular Systems Inc. (CSI), where he created/executed the commercial strategy driving revenue growth from $5M to $43M in year 1 of commercial launch. Prior to CSI, John was the US Director of Sales at Fox Hollow Technologies where he played an integral role in the aggressive revenue ramp in their early commercial years. Other successful start up’s that he was a part of prior to Fox Hollow: Novoste Corporation, Arterial Vascular Engineering and Heartport Inc. John earned his Bachelor of Science in Business Marketing from the University of Massachusetts at Lowell where he played Division 1 college hockey for four years.
Brian Strauss

Brian Strauss

Vice President of Engineering
Brian joined Inari in April 2017. Brian has an extensive background in development of novel and disruptive medical device technologies in early stage companies, consistently resulting in value creation and successful exits. He has held senior executive positions in R&D, operations, and IP development. Prior to joining Inari, Brian was Chief Technology Officer at Reverse Medical, Inc. where he was responsible for developing neurovascular catheters and devices, one of which was sold to Covidien in 2012, the others of which were sold to Medtronic as part of their acquisition of Reverse in 2014. Brian remained at Medtronic as R&D Director of their neurovascular division responsible for embolization product development. Before Reverse Medical, Brian held management and engineering positions at ev3 (acquired by Covidien), Micro Therapeutics (acquired by ev3), and Gish Biomedical (acquired by Sorin Medical). Brian holds a B.S. in mechanical engineering from the University of California, Santa Barbara, and a Masters of Business Administration from California State University, Long Beach. Brian is a named inventor on over 50 issued U.S. and international patents.
Eben Gordon

Eben Gordon

Vice President of Quality Assurance & Regulatory Affairs
Eben has extensive experience in medical device quality systems management and regulatory affairs and he joined Inari in June 2014. Prior to Inari, Eben held management positions at a number of medical device companies including, Senior Director, Regulatory Affairs At Sotera Wireless from December 2010 through June 2014. From March 2006 to August 2010, Eben served as Vice President, Regulatory Affairs and Quality Assurance at SenoRx. From May 2005 to March 2006, he was Vice President, Regulatory Affairs and Quality Assurance at ReVision Optics, a manufacturer of ophthalmic devices. From November 2001 to May 2005, Eben held various positions at Endocare, a manufacturer of devices for the treatment of urological conditions, including Vice President, Regulatory Affairs and Quality Assurance and Senior Director, Regulatory Affairs. From November 1996 to November 2001, Eben held various positions at Micro Therapeutics, including Director, Regulatory Affairs and Quality Assurance. He earned his B.S. in Zoology at California Polytechnic University.
Eric Khairy

Eric Khairy

Vice President of Marketing
Eric holds over 15 years of medical device experience in marketing, sales, strategy, and product development. Following the acquisition of Volcano by Philips in 2016, Eric progressed from leading global peripheral venous marketing to driving strategy of the peripheral vascular segment at Philips Image-Guided Therapy Devices. Joining Corindus Vascular Robotics in the company’s pre-commercial phase in 2012, Eric launched the first FDA cleared robotic-assisted system for percutaneous coronary interventions. Prior to Corindus, Eric led Intuitive Surgical’s launch and distribution of the da Vinci Surgical System in the Canadian market at Minogue Medical. Eric earned a B.Eng. in computer engineering from McGill University, an M.A.Sc. in biomedical engineering from the University of Montreal, and an MBA from the Sloan School of Management at MIT.